The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression

被引：2
|
作者：
Huang, Yong [1 ]
Zhang, KeWei [2 ]
Li, Yinghua [1 ]
Dai, Yuyin [1 ]
Zhao, Hongguang [1 ]
机构：
[1] First Hosp Jilin Univ, Dept Nucl Med, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Thorac Surg, Changchun 130021, Peoples R China
来源：
AGING-US | 2020年 / 12卷 / 22期
关键词：
papillary thyroid cancer; DLG1-AS1; miR-497; YAP1; lncRNA; LONG NONCODING RNAS; PROLIFERATION; CARCINOMA; MIGRATION; INVASION; GROWTH;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The long non-coding RNA (lncRNA), DLG1-AS1, is upregulated in papillary thyroid cancer (PTC) tissues and cell lines. Here, we found that increased expression of DLG1-AS1 caused lymph node metastasis and advanced tumor-node-metastasis (TNM) stage. DLG1-AS1 knockdown inhibited proliferation, invasion, and migration of PTC cells, and impaired tumorigenesis in vivo in mouse xenografts. DLG1-AS1 functions as a competing endogenous RNA (ceRNA) for miR-497. Further investigation revealed that DLG1-AS1 regulated yes-associated protein 1 (YAP1; a known target of miR-497) by competitively binding to miR-497. Moreover, inhibition of miR497 abrogated the inhibitory effects of DLG1-AS1 depletion on PTC cells. These findings demonstrate that the DLG1-AS1-miR-497-YAP1 axis promotes the growth and metastasis of PTC by forming a ceRNA network.
引用
收藏
页码：23326 / 23336
页数：11
相关论文
共 50 条
  • [1] miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1
    Li, Yuan
    Hua, Kaiyao
    Jin, Jiali
    Fang, Lin
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [2] MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer
    Huang, Chongbiao
    Ma, Ruijue
    Yue, Jie
    Li, Na
    Li, Zengxun
    Qi, Daliang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (01) : 342 - 352
  • [3] LncRNA ZEB1-AS1 regulates colorectal cancer cells by miR-205/YAP1 axis
    Jin, Zhong
    Chen, Bing
    OPEN MEDICINE, 2020, 15 (01): : 175 - 184
  • [4] Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules
    Tao He
    Huan Wang
    Jiangming Sun
    Jie Wu
    Fakuo Gong
    Shujun Li
    Hui Wang
    Yufeng Li
    BMC Endocrine Disorders, 19
  • [5] Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules
    He, Tao
    Wang, Huan
    Sun, Jiangming
    Wu, Lie
    Gong, Fakuo
    Li, Shujun
    Wang, Hui
    Li, Yufeng
    BMC ENDOCRINE DISORDERS, 2019, 19 (01)
  • [6] RETRACTION: miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression (Retraction of Vol 11, Pg 4711, 2018)
    Cheng, H.
    Dong, H.
    Feng, J.
    Tian, H.
    Zhang, H.
    Xu, L.
    ONCOTARGETS AND THERAPY, 2023, 16 : 47 - 47
  • [7] DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis
    Min, Jie
    Jin, Dayong
    Zhang, Feng
    Kang, Yanxia
    Qi, Yuhong
    Du, Pang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [8] DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis
    Jie Min
    Dayong Jin
    Feng Zhang
    Yanxia Kang
    Yuhong Qi
    Pang Du
    Cancer Cell International, 21
  • [9] MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1
    Chen, Lei
    Wang, Xuehui
    Ji, Changle
    Hu, Jiashu
    Fang, Lin
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (12)
  • [10] Expression of YAP1 in aggressive thyroid cancer
    Celano, Marilena
    Mignogna, Chiara
    Rosignolo, Francesca
    Sponziello, Marialuisa
    Iannone, Michelangelo
    Lepore, Saverio Massimo
    Lombardo, Giovanni Enrico
    Maggisano, Valentina
    Verrienti, Antonella
    Bulotta, Stefania
    Durante, Cosimo
    Di Loreto, Carla
    Damante, Giuseppe
    Russo, Diego
    ENDOCRINE, 2018, 59 (01) : 209 - 212
12345